Curaleaf Holdings said Tuesday it signed a $286 million definitive agreement to acquire London-based medical marijuana company Emmac Life Sciences, giving the Massachusetts-based multistate operator a major foothold in the European cannabis market and …
Europe Cannabis Industry & Marijuana Business News
Aurora says its Danish cannabis has reached German pharmacies
A subsidiary of Canada’s Aurora Cannabis says its “made in Denmark” medical cannabis products have reached some Germany pharmacies for the first time – a milestone years in the making. The German distribution comes before the products…
How a $100M global cannabis deal came together over Zoom: Q&A with IMC’s Oren Shuster
Negotiating an international cannabis merger worth roughly $100 million is hard enough – but doing so during a global pandemic is downright daunting. That’s what Israel’s IM Cannabis had to do when it agreed in late 2020 to acquire To…
Canadian marijuana producer Tilray reports $271 million loss for year
Cannabis producer Tilray cut its annual loss to $271 million for 2020, an improvement from the Nanaimo, British Columbia company’s $321 million loss in 2019, according to the full-year and fourth-quarter results released Wednesday. Tilray, which is on …
Hexo strikes deal to acquire Zenabis for CA$235M, eyes European cannabis market
Ottawa, Ontario-headquartered cannabis producer Hexo Corp. on Tuesday entered a definitive arrangement agreement to buy struggling competitor Zenabis Global for 235 million Canadian dollars ($185 million) in stock. The proposed acquisition of Vancouver…
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…
Medical cannabinoid firm GW Pharma to be acquired by Jazz Pharmaceuticals for $7.2 billion
Global pharma company Jazz Pharmaceuticals has reached an agreement to buy U.K.-based GW Pharmaceuticals, one of the largest medical cannabinoid businesses in the world, for $7.2 billion in cash and stock, the drugmakers announced Wednesday.
Medical ca…
France chooses companies to supply free medical cannabis for trial program
The French Agency for the Safety of Medicines and Health Products (ANSM) selected the companies that will supply France’s medical cannabis pilot program that’s intended to provide free products to patients enrolled in the trial. Cannabis co…
French consultation on marijuana legalization passes 200,000 responses
A consultation on cannabis legalization in France that launched on Jan. 13 has already gathered 200,354 responses, Marijuana Business Daily has learned. The consultation is not expected to prompt a near-term legislative change, but a positive outcome c…